[HTML][HTML] KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
L Zhang, X Li, Y Chao, R He, J Liu, Y Yuan… - Cell Communication and …, 2018 - Springer
Background Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
[HTML][HTML] KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
L Zhang, X Li, Y Chao, R He… - Cell …, 2018 - biosignaling.biomedcentral.com
Chemotherapeutic insensitivity remains a big challenge in prostate cancer treatment.
Recently, increasing evidence has indicated that KLF4 plays a key role in prostate cancer …
Recently, increasing evidence has indicated that KLF4 plays a key role in prostate cancer …
KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
L Zhang, X Li, Y Chao, R He, J Liu… - Cell …, 2018 - pubmed.ncbi.nlm.nih.gov
Background Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer.
L Zhang, X Li, Y Chao, R He, J Liu, Y Yuan… - … and Signaling: CCS, 2018 - europepmc.org
Background Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer.
L Zhang, X Li, Y Chao, R He, J Liu… - Cell …, 2018 - search.ebscohost.com
Background: Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
[HTML][HTML] KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
L Zhang, X Li, Y Chao, R He, J Liu, Y Yuan… - … and Signaling: CCS, 2018 - ncbi.nlm.nih.gov
Background Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
L Zhang, X Li, Y Chao, R He, J Liu, Y Yuan… - Cell Communication …, 2018 - go.gale.com
Background Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
[PDF][PDF] KLF4, a miR-32-5p targeted gene, promotes cisplatin-induced apoptosis by upregulating BIK expression in prostate cancer
L Zhang, X Li, Y Chao, R He, J Liu, Y Yuan… - 2018 - biosignaling.biomedcentral.com
Background: Chemotherapeutic insensitivity remains a big challenge in prostate cancer
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …
treatment. Recently, increasing evidence has indicated that KLF4 plays a key role in prostate …